Cited by 135Epigenetics and DNA MethylationOpioid Use Disorder TreatmentNeurotransmitter Receptor Influence on Behavior

Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts

Open access
Chorbov, PhD, Vesselin M., Todorov, PhD, Alexandre A., Lynskey, PhD, Michael T., Cicero, PhD, Theodore J.·2018·Journal of Opioid Management

Abstract

Objective: The OPRM1 gene was studied for DNA methylation in opioid dependence and possible paternal contribution to epigenetic inheritance of altered methylation profiles.Participants and methods: DNA was extracted from blood and sperm from 13 male opioid addicts and 21 male control subjects. DNA methylation was determined by pyrosequencing in 24 CpG sites at the OPRM1 promoter region.Results: The authors found significantly increased overall methylation in blood DNA from addicted subjects (Kruskal-Wallis [K-W] p = 0.013). Seven CpG sites showed significantly hypermethylated blood DNA from cases when compared with blood DNA from controls (p < 0.05 at CpGs 5, 9, 10, 11, 18, 23, and 24). In spermderived DNA from addicts, the methylation was significantly increased at CpG 2 (p = 0.012), and overall methylation did not reach significant difference (K-W p = 0.523).Conclusions: Increased DNA methylation in the OPRM1 gene is associated with opioid dependence. Hypermethylated CpG sites located in OPRM1 promoter may potentially block the binding of Sp1 and other transcription activators, thus leading to OPRM1 silencing. The increased DNA methylation in sperm may suggest a way of epigenetic heritability of opioid abuse or dependence phenotypes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5055/jom.2011.0067

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chorbov, P., Todorov, P., Lynskey, P., & Cicero, P.
Venue
Journal of Opioid Management
Published
2018-01-15
Volume
7
Issue
4
Pages
258-264
ISSN
1551-7489 (ISSN-L)
OpenAlex
W2325055448
Cited by
135
References
25
Citations by year
2026: 5 · 2025: 7 · 2024: 6 · 2023: 13 · 2022: 11 · 2021: 14 · 2020: 12 · 2019: 15 · 2018: 15 · 2017: 11 · 2016: 7 · 2015: 4 · 2014: 7 · 2013: 1 · 2012: 6
FWCI
1.82
Type
journal article
Language
en
Open access
Locations
  • Journal of Opioid Management (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute on Alcohol Abuse and Alcoholism (AA017681, K01AA017681)
  • National Institute of Mental Health (R01MH083823, MH083823)
  • National Institute on Drug Abuse (DA021330, R01DA018823, R01DA021330, DA018823)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
OPRM1, DNA methylation, promoter hypermethylation, opioid use disorder, sperm DNA methylation, blood DNA methylation, epigenetic inheritance, CpG sites, gene silencing, Sp1
MeSH terms
Adult, Analysis of Variance, Heroin Dependence, Humans, Male, Missouri, Opioid-Related Disorders, Pedigree, Promoter Regions, Genetic, Spermatozoa, Up-Regulation, Discriminant Analysis, Case-Control Studies, Sequence Analysis, DNA, Receptors, Opioid, mu, CpG Islands, DNA Methylation, Genetic Predisposition to Disease, Heredity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review